Pharmexcil and Department of Commerce Hold Regional Outreach Program in Mumbai
The Department of Commerce hosted a Regional Outreach Program and press interaction at Pharmexcil’s Mumbai office, highlighting the growth and achievements of India’s pharmaceutical exports over the past 12 years.
Industrial talks | 11/06/2026 | By News Bureau
Commerce Minister Invites Global Pharma Companies to Partner India's Growth Story
Union Commerce Minister Piyush Goyal has invited global pharmaceutical companies to partner with India’s rapidly growing healthcare sector, highlighting the country’s 7.7 percent economic growth and its transition from a generics-led market to an innovation-driven pharmaceutical hub.
Industrial talks | 09/06/2026 | By News Bureau
Telangana DCA Busts Illegal Sale of Codeine and Tramadol-Based Drugs in Medchal-Malkajgiri
The Telangana Drugs Control Administration conducted a raid on a pharmacy in Medchal-Malkajgiri district, seizing codeine-based cough syrups and tramadol-containing capsules being sold in violation of drug regulations.
Industrial talks | 04/06/2026 | By News Bureau
Twenty healthcare and biotech startups have been selected for the Pfizer INDovation IP Support Programme 2025–26, gaining funding and intellectual property guidance to strengthen innovation, commercialization and global competitiveness.
Industrial talks | 02/06/2026 | By News Bureau | 195
Alembic Pharma Names Ramesh Juneja as EVP, Human Health
Alembic Pharmaceuticals has appointed Ramesh Juneja as Executive Vice President–Human Health for its India business. Bringing leadership experience from Sun Pharma, Cipla and Reliance Retail, Juneja will spearhead sales and marketing initiatives to drive growth in Alembic’s domestic pharmaceutical business.
Industrial talks | 02/06/2026 | By News Bureau | 101
EMA Recommends XFG-Targeted COVID-19 Vaccines for 2026-2027 Immunisation Campaign
The European Medicines Agency’s Emergency Task Force has recommended updating COVID-19 vaccines to target the XFG variant for the 2026–2027 vaccination season, aiming to enhance protection against circulating SARS-CoV-2 strains.
Industrial talks | 01/06/2026 | By News Bureau | 161
Alkem Reports Record FY26 EBITDA as Revenue Grows 13.5%; Q4 Profit Before Tax Rises 40.7 Percent
Alkem Laboratories posted its highest-ever EBITDA in FY26, driven by strong growth in domestic and international businesses, improved operating leverage, and disciplined cost management. The company also reported robust fourth-quarter performance, with revenue rising 14.6 percent and PBT before exceptional items increasing 40.7 percent YoY.
Industrial talks | 29/05/2026 | By News Bureau | 129
Consultative Meeting on WHO-ICHI Framework and Traditional Medicine Health Codes Concludes
India’s Ministry of Ayush held a two-day consultative meeting on the World Health Organization (WHO)-ICHI framework and National Health Intervention Codes to advance standardised coding systems for Ayurveda, Siddha, and Unani practices under global traditional medicine classification initiatives.
Industrial talks | 28/05/2026 | By News Bureau
PCIM&H Concludes 5-Day Training Program for ASU&H Drug Regulators and Stakeholders
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) concluded a 5-day capacity building program for ASU&H drug regulators and stakeholders, aimed at strengthening regulatory knowledge, quality standards, and technical competencies across ASU&H sector.
Industrial talks | 25/05/2026 | By News Bureau
Mabylon Advances Peanut Allergy Drug MY006 After Positive Early Clinical Data
Mabylon AG has reported positive preliminary Phase Ia results for MY006, its antibody-based peanut allergy treatment candidate, while also advancing a second allergy programme targeting tree pollen allergens.
Industrial talks | 20/05/2026 | By News Bureau | 191
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy